Form 4: Predictive Oncology Director Nancy Chung-Welch Acquires and Disposes of Shares
SEC Form 4 Filing
Director Nancy Chung-Welch reports acquiring and disposing of Predictive Oncology Inc. (POAI) common stock on April 5, 2024.
Summary
- On April 5, 2024, Nancy Chung-Welch, a director of Predictive Oncology Inc. (POAI), engaged in transactions involving the company's common stock.
- She acquired 2,353 shares of common stock.
- She disposed of 21,237 shares of common stock.
- Following these transactions, the total number of shares beneficially owned by Chung-Welch is not explicitly stated in this report.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company insider.
Key Dates
| Date | Description |
|---|---|
| 04/05/2024 | Date of the reported transaction involving the acquisition and disposition of common stock. |
| 04/12/2024 | Date of signature for the report. |
Keywords
Predictive Oncology Inc., POAI, Nancy Chung-Welch, Director, Form 4, Beneficial Ownership, Securities, Common Stock, Acquisition, Disposition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.